As of Nov 19, 2026, 1 of 2 active firms rate HCM a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
HCM EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 0 analysts
Next period, 0 analysts expect HUTCHMED DRC to earn $0.00 a share (range $0.00 – $0.00), versus — a year earlier. Full-year consensus is $0.22, growing to $0.26 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 0 analysts
Revenue is expected to reach — (range — – —). Full-year consensus is $625.9M, rising to $700.8M next year.
Top analysts covering HUTCHMED DRC
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HCM.
#1
Paul Choi
Goldman Sachs · Rank #110
Neutral
$14.00+0.4% to target
Overall win rate
52%
+ Follow
#2
JL
Jack Lin
Morgan Stanley
Neutral
$13.60-2.5% to target
Coverage
—
+ Follow
#3
Dimple Gosai
B of A Securities
Buy
$20.00+43.4% to target
Coverage
—
+ Follow
#4
Alec Stranahan
B of A Securities
Buy
$17.00+21.9% to target
Coverage
—
+ Follow
HCM stock forecast FAQ
What is HCM's average 12-month price target?+
The 2 active firms with a live target average $15.50 for HUTCHMED DRC over the next 12 months, ranging from a $17.00 high to a $14.00 low, as of Nov 19, 2026.
Is HCM stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for HCM?+
The Street-high target is $17.00 (B of A Securities), and the Street-low is $14.00 (Goldman Sachs). The average of all 2 active-firm targets is $15.50.
How many active Wall Street firms cover HCM?+
2 active firms have a recognized rating on HUTCHMED DRC as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering HCM?+
Among analysts who currently cover HCM, Paul Choi of Goldman Sachs has the strongest overall Quantellect track record (Rank #110). Their current call is Neutral with a $14.00 target.
What is HUTCHMED DRC's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 0 analysts. Full-year EPS is projected at $0.22, rising to $0.26 the following year.
How much revenue is HUTCHMED DRC expected to report next quarter?+
Consensus revenue is — (range — – —). Full-year revenue is projected at $625.9M, growing to $700.8M next year.
Have analysts been upgrading or downgrading HCM lately?+
As of Nov 19, 2026, 1 of 2 active firms rate HCM a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HCM calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.